Chrome Extension
WeChat Mini Program
Use on ChatGLM

Digoxin Treatment Reverses Angiogenic Switch During HeartMate 3 Support and is Associated with Decrease Risk for Gastrointestinal Bleeding.

˜The œjournal of heart and lung transplantation/˜The œJournal of heart and lung transplantation(2020)

Cited 0|Views17
No score
Abstract
Digoxin, an inhibitor of HIF1-α signaling cascade, may contribute to a lower risk of GIB in HM3 patients by restoring angiogenic equilibrium.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined